These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
1016 related items for PubMed ID: 18000798
1. Prevention of deep vein thrombosis in cancer patients. Lee AY. Semin Thromb Hemost; 2007 Oct; 33(7):699-706. PubMed ID: 18000798 [Abstract] [Full Text] [Related]
2. Management of thrombosis in cancer: primary prevention and secondary prophylaxis. Lee AY. Br J Haematol; 2005 Feb; 128(3):291-302. PubMed ID: 15667530 [Abstract] [Full Text] [Related]
3. Treatment of venous thromboembolism in cancer patients. Petralia GA, Kakkar AK. Semin Thromb Hemost; 2007 Oct; 33(7):707-11. PubMed ID: 18000799 [Abstract] [Full Text] [Related]
4. The NCCN Clinical Practice Guidelines on Venous Thromboembolic Disease: strategies for improving VTE prophylaxis in hospitalized cancer patients. Khorana AA. Oncologist; 2007 Nov; 12(11):1361-70. PubMed ID: 18055857 [Abstract] [Full Text] [Related]
5. [Thoughts about thromboembolic events prophylaxis in cancer patients]. Pikó B, Kremer IM, Rahoty P, Bassam A, Dimák S, Kis A, Csiffári M, Rus-Gal P, Szabó Z, Veréb B, Zsilak J. Magy Onkol; 2011 Sep; 55(3):164-9. PubMed ID: 21918741 [Abstract] [Full Text] [Related]
6. Anticoagulation therapy for prevention and treatment of venous thromboembolic events in cancer patients: a review of current guidelines. Petersen LJ. Cancer Treat Rev; 2009 Dec; 35(8):754-64. PubMed ID: 19762155 [Abstract] [Full Text] [Related]
7. Low molecular weight heparins in cancer. Management and prevention of venous thromboembolism in patients with malignancies. ten Cate-Hoek AJ, Prins MH. Thromb Res; 2008 Dec; 122(5):584-98. PubMed ID: 17996281 [Abstract] [Full Text] [Related]
10. Deep-vein thrombosis in malignancy: how long should patients be treated, and with what? Merli GJ. Catheter Cardiovasc Interv; 2009 Jul 01; 74 Suppl 1():S27-34. PubMed ID: 19530157 [Abstract] [Full Text] [Related]
11. Anticoagulant use in cancer patients. Trujillo-Santos J, Monreal M. Expert Opin Pharmacother; 2011 Feb 01; 12(3):351-62. PubMed ID: 21254944 [Abstract] [Full Text] [Related]
13. Venous thromboembolism and cancer: prevention and therapy. Lee AY. Vnitr Lek; 2006 Mar 01; 52 Suppl 1():127-8, 130-1. PubMed ID: 16637461 [Abstract] [Full Text] [Related]
14. Low-molecular-weight heparin in cancer-associated thrombosis: treatment, secondary prevention, and survival. Nishioka J, Goodin S. J Oncol Pharm Pract; 2007 Jun 01; 13(2):85-97. PubMed ID: 17873108 [Abstract] [Full Text] [Related]
15. Extended thromboprophylaxis with low-molecular-weight heparins after hospital discharge in high-risk surgical and medical patients: a review. Huo MH, Muntz J. Clin Ther; 2009 Jun 01; 31(6):1129-41. PubMed ID: 19695383 [Abstract] [Full Text] [Related]
16. Lessons from French National Guidelines on the treatment of venous thrombosis and central venous catheter thrombosis in cancer patients. Farge D, Durant C, Villiers S, Long A, Mahr A, Marty M, Debourdeau P, Groupe Francophone Thrombose et Cancer (GFTC). Thromb Res; 2010 Apr 01; 125 Suppl 2():S108-16. PubMed ID: 20433988 [Abstract] [Full Text] [Related]
17. Cancer-associated venous thrombosis in the surgical setting. Behranwala KA, Williamson RC. Ann Surg; 2009 Mar 01; 249(3):366-75. PubMed ID: 19247020 [Abstract] [Full Text] [Related]
19. Low-molecular-weight heparins for the prevention and treatment of venous thromboembolism in at-risk pregnant women: a review. Duhl AJ. J Reprod Med; 2008 Sep 01; 53(9):657-66. PubMed ID: 18839817 [Abstract] [Full Text] [Related]
20. Management of venous thromboembolism and the potential to impact overall survival in patients with cancer. Saraiya B, Goodin S. Pharmacotherapy; 2009 Nov 01; 29(11):1344-56. PubMed ID: 19857150 [Abstract] [Full Text] [Related] Page: [Next] [New Search]